In-vitro Mutagenesis
Conservative Site-specific Recombination and Phase Variation
In vitro Mutagenesis
Mismatch Repair
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 31, 2026

Using Sniper-Cas9 to Minimize Off-target Effects of CRISPR-Cas9 Without the Loss of On-target Activity Via Directed Evolution
Published on: February 26, 2019
Kentaro Ishida1, Peter Gee2, Akitsu Hotta3,4
1Center for iPS Cell Research and Application (CiRA), Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan. kentaro.ishida@cira.kyoto-u.ac.jp.
Programmable nucleases like CRISPR-Cas9 offer therapeutic potential but risk off-target mutations. Careful design and genomic testing are crucial to ensure safety and efficacy in gene editing applications.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: